atai Life Sciences and Beckley Psytech announce positive topline results from the Phase 2b study of BPL-003 in patients with treatment-resistant depression.

Launched to the public in August 2022, the fintech’s profitability was fueled by a 500% revenue growth in the last 12 months. Alaan announced that it has hit profitability in UAE within the first 3 years of launch - becoming the first corporate card and spend management player in the region, and one of the fastest globally to do so.

With fresh capital, Divibank aims to consolidate itself as the leading payments platform for entrepreneurs in Latin America, tackling poor service, low approval rates, high fees, and lack of transparency from existing providers.

Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers. Reinforces potential of Nebokitug to become the first approved drug with disease-modifying activity for PSC--a deadly disorder that currently has no effective treatments.

Umoja Biopharma announced a $100 million Series C round that will help the Seattle-based company further develop its CAR T-cell immunotherapy treatments for cancer.

NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia.

This week, Parker announced a $20 million Series B fundraising round, led by Valar Ventures with support from Y Combinator. It brings their total funding to $58 million in venture backing, plus $120 million in debt financing.

Standard Bots said the acquisition of READY Robotics’ software, patents, and trademarks will enable its own software to work across robot brands.

Duetti Inc., a music financing startup focused on acquiring rights from independent artists, has secured an additional $114 million in funding to expand its business.

In a significant step towards improving cardiovascular care, several Medicare Administrative Contractors (MACs) have granted coverage for Cleerly’s AI-enabled Quantitative Coronary Topography (AI-QCT) scans.

Standard Bots is building and training robots to think for themselves with artificial intelligence - and it could bring more manufacturing to the US in the process.

Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that the first patient has been dosed in the Phase 1 clinical trial of AGX101, a novel TM4SF1-directed antibody-drug conjugate being developed for the treatment of solid cancers.

Singapore-based investment platform Syfe has been working on making wealth management more accessible in the region by offering a variety of investment products and options, all via a smartphone app. The company has now raised a $27 million Series C round to offer more products and hasten its growth in Singapore, Hong Kong and Australia.

Umoja Biopharma, Inc., a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies in oncology and autoimmunity, today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for UB-VV111.

Artificial intelligence robotics startup Standard Bots has raised $63 million over a series of deals. A majority of that funding haul is from a $39 million Series B round the startup recently closed. General Catalyst led the round, with participation from the Amazon Industrial Innovation Fund and Samsung Next.

Tether, the largest company in the digital asset industry, announced today that it has made a strategic investment of $200 million into Blackrock Neurotech, the globally leading pioneer for Brain-Computer-Interface (BCI) technology.

While its peers are struggling, ecommerce roll-up firm Una Brands claims to have achieved EBITDA profitability in the fourth quarter of 2023, following measures to reallocate resources and cut costs.

Berlin-based Razor Group is buying Boston-based Perch in an all-stock deal, accelerating the consolidation of “aggregators” that snapped up popular online brands.

Berlin’s Razor Group has acquired U.S.-based Perch, and on top of this it has raised just over $100 million led by Presight Capital with other undisclosed investors participating.

Duetti, a company that launched last May and buys the rights to songs from independent artists, has raised $90 million to build its staff and do more deals.

SmithRx closed a Series C funding round led by Venrock to continue delivering improved pharmacy benefits and reduced prescription costs.

Nuclear engineering startup Transmutex has raised $23.2 million to produce energy and nuclear fuel from radioactive waste.

Alto Neuroscience, a Phase 2 biotech developing biomarker-focused therapies for depression and schizophrenia, announced terms for its IPO on Monday.

Alto Neuroscience, a Phase 2 biotech developing biomarker-focused therapies for depression and schizophrenia, filed on Friday with the SEC to raise up to $100 million in an initial public offering.

AbbVie (NYSE: ABBV), and Umoja Biopharma (Umoja), an early clinical-stage biotechnology company, today announced two exclusive option and license agreements to develop multiple in-situ generated CAR-T cell therapy candidates in oncology using Umoja's proprietary VivoVecTM platform.

Atai Life Sciences NV agreed to acquire a stake in smaller rival Beckley Psytech to expand its portfolio of drug candidates for the treatment of mental health conditions.

Treatment with ALTO-300 led to a significantly greater improvement in depression symptoms in a biomarker-characterized patient population.

Alto Neuroscience today announced an oversubscribed $45 million Series C financing. The round was led by InVivium Capital, with participation from additional new investors Franklin Templeton, Point72, Eli Lilly and Company, and Alexandria Venture Investments.

Angiex announces FDA clearance of IND application for AGX101, a novel, first-in-class TM4SF1-directed antibody-drug conjugate for the treatment of solid cancers.

ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.

Alto Neuroscience Inc. reported results from the post-traumatic stress disorder (PTSD) cohort in its Phase 2a study of ALTO-100, demonstrating clear evidence of efficacy and favorable safety in patients with PTSD.

In both patient cohorts followed for six months after PLG0206 treatment, there were no treatment-related serious adverse events and no recurrence was observed in 13 of 14 (93%) treated patients at Day-180 in contrast to reported 180-day success rate of 45%.

Hoxton Farms, the London-based biotech developing cultivated animal fat, opens on September 21st its first pilot facility in the center of London to advance research, enable industry scale-up production and develop prototypes with plant-based companies and supermarkets chains.

Longevity biotech opens strategic Abu Dhabi office as Mubadala Capital joins Series B investment round.

PandaDoc, a leading all-in-one quote-to-cash and contract automation platform, announced the acquisition of German fintech startup Denario, an innovative B2B SaaS company specializing in payment management solutions.

London startup has the antiquated clinical trials sector in its crosshairs. Backed by Peter Thiel, Lindus Health is a "next-gen" contract research organization that makes it faster and easier to run clinical trials.

Cleerly, the company creating a new standard of care for heart disease, today announced that it has been named “Best Overall AI Solution” in the sixth annual AI Breakthrough Awards program conducted by AI Breakthrough.

"We're not some financial firm that sits back and is waiting for the income to come in, we're very active in management," says co-founder Lior Tibon.

The music financing platform is bringing investment opportunities to the fastest growing segment of the music industry and giving independent artists the ability to sell their masters. Backed by $32M in funding from Viola Ventures and Viola Credit, Roc Nation, Untitled and Presight Capital, Duetti is uniquely positioned to disrupt the music financing market.

Razor Group, one of the string of startups that has made a name for itself as a “roll-up” startup — raising big money to acquire and consolidate Amazon (and other marketplace) retailers — is now making a different kind of consolidation play. The Berlin startup has acquired one of its competitors in the aggregator space, Stryze Group, as part of a bid to be “the consolidator of consolidators.”

Northstar Group, a regional private equity firm, is the sole investor in Una Brands’ latest round, which involves a mix of equity and debt. The company has now raised more than $100 million in total funding since its inception in 2021.

NewAmsterdam Pharma Company announced topline results from a Phase 2 clinical trial evaluating obicetrapib, the company’s oral, low-dose and once-daily cholesteryl ester transfer protein (“CETP”) inhibitor, in combination with ezetimibe as an adjunct to high-intensity statin therapy.

On Day 2 of the annual J.P. Morgan Healthcare Conference, Alto’s founder and CEO Amit Etkin, MD, PhD, details the company’s Precision Psychiatry Platform and the safety and efficacy of ALTO-100 in patients with major depressive disorder (MDD).

UAE-based spend management platform Alaan said Monday that it raised $4.5 million in a Pre-Series A funding round led by Presight Capital and Y Combinator with the participation of other angel investors, bringing its total funding to $7 million.

$70 Million Financing Round led by L Catterton to Support Razor’s Leadership as a Global E-Commerce Operator. Razor Group Acquires VALOREO to Advance Global Growth Strategy.

Following a successful expansion from antibodies into T-cell receptors and genetic medicines, Alloy will broaden its pre-competitive discovery technology and discovery services to enable innovative new therapeutic formats.

Qonto, the French business banking unicorn, today announced plans to acquire German fintech Penta. The deal is expected to close in the next few weeks, and will help Qonto push hard into Germany — where it hopes to become the market leader.

While most animal-milk alternatives have their own unique tastes and textures, Perfect Day has devised a way of “teaching” microflora to produce milk whey protein, resulting in dairy-identical products with no cows involved.

Mexico-based startup Valoreo is one surfing the wave of capital inflows for brand aggregators. After raising a $30 million Series A round in July 2021, the company is now securing its Series B, an $80 million round led by the private equity firm L Catterton.

Cloud Paper is a sustainable, bamboo-based alternative to toilet paper made from tree-free materials. The company raised a $5 million round from Bezos Expeditions (the personal investment company of Jeff Bezos), Marc Benioff’s TIME Ventures, Presight Capital, Soundwaves and Jeff Wilke.

Fintech startup Velocity has raised $20 million in a Series A round led by Peter Thiel’s Valar Ventures and other investors including Presight Capital, iSeed, Maninder Gulati, Zac Price and Philippe De Mota. 

In the latest development, Berlin’s Razor Group has now raised $125 million of equity funding in a Series B round that CEO and co-founder Tushar Ahluwalia said pushes the company past a $1 billion valuation.

A consortium of lenders, including freshly minted unicorn OfBusiness, Innoven Capital, and Alteria Capital, have also committed capital to the platform.

Singapore-based ecommerce aggregator Una Brands said it has raised US$40 million in its seed round of equity and debt financing, marking one of the biggest seed funding rounds in the region.

Presight Capital has closed its $350 million second fund only a year and a half after it announced an $80 million first fund.